AMBEREEN GHANI: Open Payments
NPI 1548468127 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,725 in 90 payments from 17 companies in 2025. Trend: 2023 $2,302 · 2024 $2,979 · 2025 $2,725
Food & beverage: $2,725
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $852 |
| Amgen Inc. | 13 | $356 |
| Novo Nordisk Inc | 10 | $319 |
| Lilly USA, LLC | 15 | $257 |
| Sumitomo Pharma America, Inc. | 3 | $172 |
| PFIZER INC. | 7 | $167 |
| Phathom Pharmaceuticals, Inc. | 4 | $154 |
| ABBVIE INC. | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Exact Sciences Corporation | 3 | $66 |
Products named: FARXIGA, Ozempic, BREZTRI, GEMTESA, AIRSUPRA, VOQUEZNA, NURTEC ODT, JARDIANCE.
Industry payments across IL — which companies pay providers there.
